DV
Dividend Vision

AVXL — Anavex Life Sciences Corp

Anavex Life Sciences Corp (AVXL)

Total return is -59.7% over the past 20 years, 835.1 points behind SPY at 775.4%. Its deepest 1-year drawdown was 77.8%.

AVXL is an equity stock that focuses on Anavex Life Sciences Corp, a single-company holding rather than a diversified fund. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. This holding appeals primarily to investors interested in direct exposure to Anavex Life Sciences' business operations and potential capital appreciation rather than dividend yield.

AVXL key facts

Asset type
Stock
Asset class
Equity
Inception date
08/02/2006
Last close
$3.22
Market cap
$221,485,520
Average volume
698100.0
Beta
1.139
Payout ratio
0.0
Forward P/E
3.8521
EPS
$-0.46